CSF Analysis Differentiates Multiple-system Atrophy from Idiopathic Late-onset Cerebellar Ataxia
Authors
Affiliations
Background: Differentiating idiopathic late-onset cerebellar ataxia (ILOCA) from ataxia due to the cerebellar subtype of multiple-system atrophy (MSA-C) can be difficult in the early stages of the disease
Methods: The authors analyzed the levels of various CSF biomarkers in 27 patients with MSA-C and 18 patients with ILOCA and obtained cut-off points for each potential biomarker to differentiate MSA-C from ILOCA.
Results: Increased levels of neurofilament light chain (NFL) and neurofilament heavy chain (NFHp35) and decreased levels of the neurotransmitter metabolites homovanillic acid (HVA), 5-hydroxyindoleaceticacid (5-HIAA), and 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) were observed in MSA-C compared with ILOCA patients. Receiver operating characteristic analysis showed high sensitivity and specificity levels for NFL, NFHp35, and MHPG analysis. At a cut-off of 24.4 ng/L for the NFL analysis, a sensitivity of 79% and a specificity of 94% were obtained for differentiating MSA-C from ILOCA. At a cut-off point for NFHp35 of 129.5 ng/L, sensitivity was 87% and specificity 83%. Analysis of MHPG levels (cut-off 42.5 nM) resulted in a sensitivity of 86% with a specificity of 75%. A multivariate logistic regression model selected NFL, MHPG, and tau as independent predictive biomarkers that separated the MSA-C and ILOCA groups.
Conclusions: Increased levels of neurofilament light chain and tau and decreased levels of 3-methoxy-4-hydroxyphenylethyleneglycol were associated with high accuracy levels in differentiating the cerebellar subtype of multiple-system atrophy from idiopathic late-onset cerebellar ataxia (LOCA). CSF analysis may thus serve as a useful tool in early diagnostic differentiation of LOCA.
Liu M, Cai Y, Pan J, Wang T, Li Y, Yu Q J Neurol. 2024; 272(1):74.
PMID: 39680179 DOI: 10.1007/s00415-024-12784-5.
Correlations between serotonin impairments and clinical indices in multiple system atrophy.
Nagao R, Mizutani Y, Shima S, Ueda A, Ito M, Yoshimoto J Eur J Neurol. 2023; 31(3):e16158.
PMID: 38085271 PMC: 11235942. DOI: 10.1111/ene.16158.
Takekoshi A, Kimura A, Yoshikura N, Yamakawa I, Urushitani M, Nakamura K Cerebellum. 2022; 22(5):915-924.
PMID: 36057079 DOI: 10.1007/s12311-022-01468-3.
Singer W Clin Auton Res. 2022; 32(4):291-297.
PMID: 35895157 PMC: 10101699. DOI: 10.1007/s10286-022-00882-1.
Singer W, Schmeichel A, Shahnawaz M, Schmelzer J, Sletten D, Gehrking T Ann Neurol. 2021; 89(6):1212-1220.
PMID: 33881777 PMC: 8168720. DOI: 10.1002/ana.26089.